National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 83895-83896 [2024-24058]

Download as PDF Federal Register / Vol. 89, No. 202 / Friday, October 18, 2024 / Notices also attend the meeting via webcast. Instructions for attending via webcast will be posted at least one week prior to the meeting at https://www.hhs.gov/ ohrp/sachrp-committee/meetings/ index.html. Julia Gorey, J.D., Executive Director, SACHRP; U.S. Department of Health and Human Services, 1101 Wootton Parkway, Suite 200, Rockville, Maryland 20852; telephone: 240–453– 8141; fax: 240–453–6909; email address: SACHRP@hhs.gov. SUPPLEMENTARY INFORMATION: Under the authority of 42 U.S.C. 217a, section 222 of the Public Health Service Act, as amended, SACHRP was established to provide expert advice and recommendations to the Secretary of Health and Human Services, through the Assistant Secretary for Health, on issues and topics pertaining to or associated with the protection of human research subjects. The SACHRP Advisory Subcommittee was established by in August 2024 and is charged with assessing and drafting recommendations for consideration by SACHRP pertaining to the language and interpretation of 45 CFR part 46, existing relevant HHS guidance documents and the development of new HHS guidance documents, and cultural, ethical, or international issues of concern which may impact HHS funded human subjects protections. The SACHRP meeting will open to the public at 11:00 a.m., on Tuesday, October 22, 2024, followed by opening remarks from Julie Kaneshiro, currently Acting Director of OHRP. Ms Kaneshiro will introduce Dr. Molly Klote, newly appointed Director of OHRP. Dr. Douglas Diekema, SACHRP Chair, will make opening remarks. The meeting will begin with a discussion of the draft recommendation, Considerations for Uninformative Research. This will be followed by panel presentations and discussion of a new SACHRP topic on Equivalent Protections and Procedural Requirements in International Research. The day will adjourn at approximately 4:30 p.m. Time will be allotted for public comment. SACHRP materials will be publicly posted at HHS–OASH–2024– 0013. The public may submit written public comment in advance to SACHRP@hhs.gov no later than midnight October 18th, 2024, ET. Written comments will be shared with SACHRP members and may read aloud during the meeting. Comments which are read aloud are limited to three minutes each. Public comment must be khammond on DSKJM1Z7X2PROD with NOTICES FOR FURTHER INFORMATION CONTACT: VerDate Sep<11>2014 16:48 Oct 17, 2024 Jkt 265001 relevant to topics currently being addressed by the SACHRP. Dated: September 26, 2024. Julia G. Gorey. Executive Director, SACHRP, Office for Human Research Protections. [FR Doc. 2024–24147 Filed 10–17–24; 8:45 am] BILLING CODE 4150–36–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. This will be a hybrid meeting held inperson and virtually and will be open to the public as indicated below. Given the capacity constraints of the venue, the public is strongly encouraged to attend virtually via NIH videocast. Interested individuals should pre-register at https://cvent.me/vxOKqy to attend this meeting. Individuals who need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocasting website (https://videocast.nih.gov/). Name of Committee: Scientific Management Review Board. Date: November 12, 2024. Time: 11:15 a.m. to 5:30 p.m. Agenda: Overview of NIH’s mission, structure, and budget and summary of SMRB’s history and future directions. Address: National Institutes of Health, Building 31, 6C Room F & G, 31 Center Drive, Bethesda, MD 20894. Meeting Format: Hybrid Meeting. Contact Person: Tyrone Spady, Ph.D., Acting Senior Advisor to the NIH Deputy Director, Office of the Director, One Center Drive, Building 1, Room 108, Bethesda, MD 20892, (301) 496–2433, smrb@nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a government- PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 83895 issued photo ID, driver’s license, or passport) and to state the purpose of their visit. The draft meeting agenda and other information about the SMRB, including information about access to the webcast, will be available prior to the meeting at https:// smrb.od.nih.gov. (Catalogue of Federal Domestic Assistance Program Numbers: 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS.) Dated: October 15, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–24125 Filed 10–17–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Bat Immunology Network Research Projects (R01 Clinical Trial Not Allowed) and Bat Immunology Network Research Resource Program (U24 Clinical Trial Not Allowed). Date: November 25–26, 2024. Time: 10:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892. Meeting Format: Video Assisted Meeting. Contact Person: Sandip Bhattacharyya, Ph.D., Scientific Review Officer, Scientific E:\FR\FM\18OCN1.SGM 18OCN1 83896 Federal Register / Vol. 89, No. 202 / Friday, October 18, 2024 / Notices Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, MSC 9834, Rockville, MD 20892, sandip.bhattacharyya@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: October 11, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–24058 Filed 10–17–24; 8:45 am] BILLING CODE 4140–01–P Dated: October 11, 2024. Lauren A. Fleck, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–24057 Filed 10–17–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2024–0783] Area Maritime Security Advisory Committee for Gulf of Mexico Coast Guard, DHS. Solicitation for membership. AGENCY: ACTION: DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting khammond on DSKJM1Z7X2PROD with NOTICES Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed). Date: November 14, 2024. Time: 9:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Address: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892. Meeting Format: Video Assisted Meeting. Contact Person: James T. Snyder, Ph.D., Scientific Review Officer, Scientific Review Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, MSC 9823, Rockville, MD 20892, (240) 669–5060, james.snyder@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) VerDate Sep<11>2014 16:48 Oct 17, 2024 Jkt 265001 The Coast Guard requests individuals interested in serving on the Gulf of Mexico Area Maritime Security Advisory Committee (AMSC) Executive Steering Committee submit their applications for membership to the Federal Maritime Security Coordinator (FMSC), Eighth Coast Guard District. DATES: Requests for membership should reach the Eighth Coast Guard District by November 30, 2024. ADDRESSES: Applications for membership should be submitted to the FMSC at the following address: Commander, Eighth Coast Guard District, Attn: Mr. Nick Alphonso, Gulf of Mexico AMSC Executive Secretary, Hale Boggs Federal Building, 500 Poydras St., Suite 1341, New Orleans, LA 70130. Applications can also be emailed to: Nicholas.J.Alphonso2@ uscg.mil. FOR FURTHER INFORMATION CONTACT: For questions about applying or about the AMSC Executive Steering Committee in general, contact Mr. Nick Alphonso, Gulf of Mexico AMSC Executive Secretary, Phone: (504) 671–2267, Nicholas.J.Alphonso@uscg.mil. SUPPLEMENTARY INFORMATION: SUMMARY: I. Authority Section 102 of the Maritime Transportation Security Act (MTSA) of 2002 (Pub. L. 107–295, 116 Stat. 2064) added section 70112 to Title 46 of the U.S. Code, and authorized the Secretary of the Department in which the Coast Guard is operating to establish Area Maritime Security Advisory Committees for any port area of the United States. (See 33 U.S.C. 1226; 46 U.S.C. 70112; 33 CFR 1.05–1, 6.01; Department of Homeland Security Delegation No. 00170.1(II)(71), Revision No. 01.4). The MTSA includes a provision exempting these AMSCs from the Federal Advisory Committee Act, (Pub. L. 117–286, 5 PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 U.S.C., ch. 10). The AMSCs assist the FMSC in the development, review, updating, and exercising of the Area Maritime Security Plan for their area of responsibility. Such matters may include, but are not limited to: identifying critical port infrastructure and operations; identifying risks (threats, vulnerabilities, and consequences); determining mitigation strategies and implementation methods; Developing strategies to facilitate the recovery of the Maritime Transportation System after a Transportation Security Incident; developing and describing the process to continually evaluate overall port security by considering consequences and vulnerabilities, how they may change over time, and what additional mitigation strategies can be applied; and providing advice to, and assisting the FMSC in developing and maintaining the AMSP. II. AMSC Composition The composition of an AMSC Executive Steering Committee is prescribed under 33 CFR 103.305. Pursuant to that regulation, members may be selected from the Federal, Territorial, or Tribal government; the State government and political subdivisions of the State; local public safety, crisis management, and emergency response agencies; law enforcement and security organizations; maritime industry, including labor; other port stakeholders having a special competence in maritime security; and port stakeholders affected by security practices and policies. Members of the AMSC should have at least five years of experience related to maritime or port security operations. III. AMSC Membership The Gulf of Mexico AMSC Executive Steering Committee currently has 6 members. We are seeking to add 10 to 15 members with this solicitation. Applicants may be required to pass an appropriate security background check prior to appointment to the committee. Members’ terms of office will be for five years; however, a member is eligible to serve additional terms of office. Members will not receive any salary or other compensation for their service on the AMSC. IV. Request for Applications Those seeking membership are not required to submit formal applications to the local FMSC; However, because the Gulf of Mexico AMSC Executive Steering Committee does have an obligation to ensure that a specific number of members have the prerequisite maritime security E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

[Federal Register Volume 89, Number 202 (Friday, October 18, 2024)]
[Notices]
[Pages 83895-83896]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24058]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Bat Immunology Network Research 
Projects (R01 Clinical Trial Not Allowed) and Bat Immunology Network 
Research Resource Program (U24 Clinical Trial Not Allowed).
    Date: November 25-26, 2024.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Rockville, MD 
20892.
    Meeting Format: Video Assisted Meeting.
    Contact Person: Sandip Bhattacharyya, Ph.D., Scientific Review 
Officer, Scientific

[[Page 83896]]

Review Program, Division of Extramural Activities, National 
Institute of Allergy and Infectious Diseases, National Institutes of 
Health, 5601 Fishers Lane, MSC 9834, Rockville, MD 20892, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: October 11, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-24058 Filed 10-17-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.